- Home
- IOVA vs LVWR Comparison
IOVA vs LVWR Comparison
Compare IOVA & LVWR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IOVA
- LVWR
- Stock Information
- Founded
- IOVA 2007
- LVWR 2022
- Country
- IOVA United States
- LVWR United States
- Employees
- IOVA N/A
- LVWR N/A
- Industry
- IOVA Biotechnology: Biological Products (No Diagnostic Substances)
- LVWR
- Sector
- IOVA Health Care
- LVWR
- Exchange
- IOVA Nasdaq
- LVWR Nasdaq
- Market Cap
- IOVA 975.1M
- LVWR 914.8M
- IPO Year
- IOVA N/A
- LVWR N/A
- Fundamental
- Price
- IOVA $2.30
- LVWR $5.30
- Analyst Decision
- IOVA Buy
- LVWR
- Analyst Count
- IOVA 11
- LVWR 0
- Target Price
- IOVA $11.90
- LVWR N/A
- AVG Volume (30 Days)
- IOVA 10.8M
- LVWR 172.6K
- Earning Date
- IOVA 11-06-2025
- LVWR 10-23-2025
- Dividend Yield
- IOVA N/A
- LVWR N/A
- EPS Growth
- IOVA N/A
- LVWR N/A
- EPS
- IOVA N/A
- LVWR N/A
- Revenue
- IOVA $241,525,000.00
- LVWR $23,822,000.00
- Revenue This Year
- IOVA $67.40
- LVWR $249.13
- Revenue Next Year
- IOVA $56.32
- LVWR $98.53
- P/E Ratio
- IOVA N/A
- LVWR N/A
- Revenue Growth
- IOVA 636.99
- LVWR N/A
- 52 Week Low
- IOVA $1.64
- LVWR $0.93
- 52 Week High
- IOVA $12.51
- LVWR $9.04
- Technical
- Relative Strength Index (RSI)
- IOVA 50.67
- LVWR 68.76
- Support Level
- IOVA N/A
- LVWR $4.64
- Resistance Level
- IOVA $2.46
- LVWR $5.36
- Average True Range (ATR)
- IOVA 0.14
- LVWR 0.44
- MACD
- IOVA -0.09
- LVWR 0.17
- Stochastic Oscillator
- IOVA 92.00
- LVWR 96.73
About IOVA Iovance Biotherapeutics Inc.
Iovance Biotherapeutics Inc is a clinical-stage biopharmaceutical company, pioneering a transformational approach to treating cancer by harnessing the human immune system's ability to recognize and destroy diverse cancer cells using therapies personalized for each patient. The company is preparing for potential U.S. regulatory approvals and commercialization of the first autologous T-cell therapy to address a solid tumor cancer. its objective is to be the leader in innovating, developing, and delivering tumor-infiltrating lymphocyte, or TIL, therapies for patients with solid tumor cancers.
About LVWR LiveWire Group Inc.
LiveWire Group Inc is an all-electric vehicle company. It sells electric vehicles and related parts and accessories and apparel in the United States and certain international markets. The company's segment includes Electric Motorcycles and STACYC. Electric Motorcycles segment sells electric motorcycles, related parts and accessories and apparel in the United States and certain international markets; STACYC segment sells electric balance bikes for kids, related parts and accessories and apparel in the United States and certain international markets. LiveWire generates revenue from the sale of electric motorcycles, Parts, accessories and apparel. Majority of revenue is from USA.